NASDAQ
0.61USD
+0.61 (+100.00%)
We have scored 4 news catalysts on 23andMe Holding Co. (ME) over the past 12 months. The biggest single-day move next to one of them came Jul 7, 2026, when ME closed +0.0%: “Judge approves $46.75 million payout for 23andMe data breach victims”. Coverage across the window leans negative (average ticker sentiment −0.30). Most of the impact sits in sector healthcare and sector industrials.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
15.3M
P/E
—
EPS
—
Beta
1.20
52W range
0.48-12.76
Day range
0.61–0.61
Open
0.61
Prev close
0.61
Volume
29.8M
Avg volume
4.1M
Dividend
0.00
IPO
2020-11-23
23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications. The Therapeutics segment is dedicated to pharmaceutical research and development, focusing on the discovery and advancement of novel treatments aimed at improving patient well-being across diverse medical fields, including oncology, respiratory, and cardiovascular diseases. This segment also engages in the out-licensing of intellectual property associated with identified drug targets that are progressing through clinical development. 23andMe maintains a strategic partnership with GlaxoSmithKline Intellectual Property (No.3) Limited, leveraging genetic insights to validate, develop, and ultimately commercialize new pharmaceutical products. Established in 2006, the company's corporate headquarters are situated in South San Francisco, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about 23andMe Holding Co. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of 23andMe Holding Co., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for ME: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
